Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Innovation Council · Running

NeuroClues: the clinical must-have for Neurologist NeuroClues: the clinical must-have for Neurologists: clinical validation, industrialization, and go-to-market.

Coordinator
P3 Lab, Belgium
Runs
1 February 2023 to 31 January 2027
Status
Running
EU funding
€2.5m
Total cost
€5.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190152225

What the project is doing

In the project's own words, from its summary on CORDIS.

P3Lab developed NeuroClues, a first-of-a-kind portable, fast and easy to use eye tracking medical device that brings clinically validated eye movement biomarkers for movement disorders (MDs) into the clinical routine of neurologists. NeuroClues will enable neurologists to establish their MD diagnosis faster (from months to days) earlier and more reliably, and with diagnostic grade accuracy. This will enable neurologists to start patient care earlier.

This project aims at validating and demonstrating (I) the usability of NeuroClues in the clinical routine with early adopter KOL neurologists and (II) assess its clinical value in ongoing and (III) in own sponsored clinical investigation studies (EU and US). This is needed to convince the broad majority of neurologist of NeuroClues’ clinical value. The successful demonstration and accompanied development of our go-to-market strategy will enable P3Lab to become investor ready by 2024 and profitable by 2027, with €70M ARR targeted by 2030.

Who is involved

OrganisationCityCountryRole
P3 LabOttignies-Louvain-La-NeuveBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI